Introduction
Nearly 400 chemicals have been assessed for carcinogenicity by the U.S. National Toxicology Program (NTP) . A review of 301 of these chemicals was recently undertaken (1) . Certain trends in the database were recongized, trends that may be worth pursuing among the much larger databases available beyond the NTP. A visualization of the database is provided in Figure 1 . Here the chemicals are distributed in two dimensions. First, the cancer bioassay results are in order as follows: A, trans-species carcinogens; B, single species/multiple-site carcinogens; C, single species/single-site carcingogens; D, single sex/species/site carcinogens. Class Eis agents equivocal for carcinogenicity, and Frepresents two-species noncarcinogens. The second segregation is into six broad classes based on key aspects ofthe chemical structure of each agent (see legend to Fig. 1 ). The assignments ofan alert to potential electrophilicity were based on the megastructure recently presented by Tennant and Ashby (2) . If a chemical was mutagenic to Salmonella, a filled symbol is used in Figure 1 . From Figure 1 , it is evident that the database is segregated into two broad groups: alerting and mutagenic carcinogens and structurally benign nonmutagens, most of which are noncarcinogenic. What is particularly relevant is that the vast majority ofthe structurally alerting two-species carcinogens are mutagenic to Salmonella, whereas the vast majority ofthe structurally nonalerting noncarcinogens are nonmutagenic to Salmonella. An alternative view ofthese conclusions is given in Figure 2 . In Figure 2 it becomes even clearer that a significant number of carcinogens are devoid of alerts to potential DNA reactivity and are nonmutagenic to Salmonella. Whether or not *ICI Centrl Toxicology Laboratory, Alderley Park, Cheshire, UK. these chemicals are called nongenotoxic carcinogens is a matter ofwords; the real issue is how to predict further carcinogens of these types. It is at this point that the simple answer presents, namely, conducting multiple in vitro genotoxicity assays in the hope that at least one assay will find such agents positive. Whenever this has been done, the successful assay finds an equal proportion ofnoncarcinogens positive, thereby calling into question the relevance of all of the positive findings.
There is currently a growing literature that indicates many of these presumed nongenotoxic carcinogens to be active not by virtue ofhidden genotoxic activities, but by virtue ofsubtle changes they induce in rodent tissue homeostasis. That implies that the prediction ofsuch carcinogens will lie in studying rodent tissue homeostasis and its chemical disturbance, not in conducting multitudinous in vitro genotoxicity assays. Ifthat conclusion is valid, it has major implications for the design and interrogation of the major mutation/cancer databases. To be specific, the Genetic Activity Profiles (GAP) developed by Waters (3) ofthe U.S. EPA should perhaps contain entries on thyroid function/toxicity effects if they are ever to contribute to the prediction of thyroid-specific carcinogens; amassing genotoxicity data may not be enough. Similar considerations should perhaps also apply to artificial intelligence structure-activity programs such as CASE (4) .
Finally, it is important to accept that both mutagenicity and carcinogenicity represent a continuum, starting with potent genotoxic mutagens and carcinogens, through probable nonmutagenic carcinogens on to nonmutagenic noncarcinogens. It is therefore potentially dangerous to reduce both mutagenicity and carcinogenicity to singular (plus or minus) phenomena. Among databases discussed during this meeting, only that of The stated aim of this meeting was to increase mutual awareness ofthe many genotoxicity/carcinogenicity databases in existence and to enhance their consolidation and interaction. Those aims were surely achieved. However, recognition of the sheer magnitude of the databases available prompted many discussions ofwhy they were not yielding greater progress in the science of mammalian carcinogen prediction. The fact that such discussions were lively and constructive is a hopeful sign, but they are easily forgotten when returning to the grind of enlarging the databases themselves. With that in mind, some of those discussions are captured herein for wider consideration. All of the topics discussed here are related to the chapters preceding this one, so referencing is minimal. Attribution of specific comments or ideas is limited to instances where they provide a valuable context for the comment.
Information versus Knowledge
The late Malcolm Muggeridge commented on a recent war that the several spokesmen provided a maximum ofinformation that yielded a minimum of knowledge. The prospect that the same phenomenon is happening with our current databases was noted on several occasions. A measure of the knowledge available comes from the correlation coefficient between two data sets that are assumed to be related. Correlation coefficients of 0.4 to 0.7 were the average, and this confirms that no simple relationships exist for all chemicals. At the best, therefore, compromises will have to be made if existing data are to be used to predict effects for untested chemicals. It is interesting to wonder why this science remains as stable as it is given the poor overall correlations observed between any of the parameters studied (cancer versus mutation, etc.). This continued viability must be based on a deep feeling that meaningful correlations do exist, but that they are blurred by a range ofcomplicating factors that can eventually be recognized and corrected. An analogy of relevance happened during the meeting. Before the meeting, a conservative estimate would be that a large proportion of the population of the earth (6) that has several thousand entries, but which are of less even quality. A related and endemic concern is that protocols have advanced dramatically over the past decade, and it is known to follow that a large proportion of the earlier data in the more established databases would not be acceptable for entry ifconsidered today.
Level of Effect
Perhaps this is the major challenge to any database-to maintain a core ofacceptable studies and data sets with which to conduct critical correlations among databases. The view was expressed that all databases should represent a repository of all available data, with subsets ofacceptable data being accessed by individual investigators as appropriate to their needs. This view was not generally supported; there was strong support for storing adequate data and rejecting inadequate material.
The Every Dta Set TeUls Us Something Syndrome. The early failure to discern simple correlations between genotoxicity data and rodent cancer data led to the proliferation of assays. Thus, the GAP format can contain up to -200 individual assay entries. This poses the question of what possible need there can be to generate such a database on any chemical. The question was also posed as to whether or not data entries in GAP (and the ICPEMC data format) should be limited to those derived from the 10 to 12 major assays in current use. Several answers to this question were implied, none ofwhich is very credible and each ofwhich will inevitably sustain the current blizzard of information: a) It is too early to decide which assays to omit. b) Data from any assay can add subtle refinement to the overall picture ofthe genotoxicity ofa chemical. c) Even ifassay data do not correlate with carcinogenicity, they may provide important information on mutagenicity.
The cyclic nature ofthese three mutuallly supporting answers is evident. Several speakers commented that the available evidence indicates that some assays (e.g., SCE or L5178Y in vitro) have no correlation with carcinogenicity, yet they are still used for this purpose. The above listed three answers were used to short ciruit that observation. At break up the databases into speculative subgroups (e.g., genotoxic/nongenotoxic; the bases can easily be remerged) and seek the meaningful correlation that surely exists amid the present sea of information. 7 . We should all accept the futility of seeking simple correlations in mutagenesis/carcinogenesis that could apply to all chemicals and all end points. 8 . The prospect that a totally new type of structure-activity relationship will underpin nongenotoxic carcinogenesis means that a new approach to the prediction ofthese effects must be considered. The will to cooperate evidenced at this meeting provides hope that true progress in protecting the human genome can be made.
